WebApr 14, 2024 · Edwards Lifesciences Co. has a 52-week low of $67.13 and a 52-week high of $131.10. The stock has a 50-day simple moving average of $79.72 and a 200-day simple moving average of $78.31. Edwards ... WebApr 10, 2024 · The company has a market cap of $50.84 billion, a PE ratio of 34.38, a P/E/G ratio of 4.88 and a beta of 1.02. The stock has a fifty day moving average price of $79.45 and a 200 day moving average price of $78.26. Edwards Lifesciences Co. has a 1-year low of $67.13 and a 1-year high of $131.10. Edwards Lifesciences ( NYSE:EW - Get …
Edwards Lifesciences Corp - Edwards RESILIA Tissue Aortic Valve ...
WebApr 9, 2024 · In other Edwards Lifesciences news, VP Daveen Chopra sold 4,000 shares of the business's stock in a transaction on Wednesday, February 15th. The shares were sold at an average price of $76.01, for a total transaction of $304,040.00. Following the completion of the sale, the vice president now owns 18,911 shares in the company, … WebApr 14, 2024 · Signaturefd LLC reduced its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Get Rating) by 16.4% during the fourth quarter, according to the company … screener redington
EDWARDS LIFESCIENCES ANNOUNCES CEO SUCCESSION PLAN
WebSummary. Daveen Chopra is on the board of OCTANe and Edwards Lifesciences Foundation and Vice President-Surgical Structural Heart at Edwards Lifesciences … WebJan 15, 2024 · Daveen Chopra, Edwards Lifesciences: Degenerative mitral valve regurgitation is a type of heart disease. It’s commonly caused by mitral valve prolapse, a … WebApr 9, 2024 · Insider Buying and Selling at Edwards Lifesciences. In other news, VP Daveen Chopra sold 4,000 shares of the stock in a transaction that occurred on … screener quarterly results